Syndax Pharmaceuticals (SNDX) Q4 2025 Earnings

Nov 3Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.25
-1.07
-0.88
-0.7

Details

Expected EPS
-0.724485
Actual EPS
-0.7
Surprise EPS
0.02
Surprise Percent
+3.38%

Description

⁨Syndax Pharmaceuticals⁩ (⁦SNDX⁩) has reported earnings of ⁦-0.7⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts